$0.3901-2.50%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →PharmaCyte Biotech last closed at $0.3901 (-2.50%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -0.3×. Its overall grade ranks 544 of 741 stocks in Healthcare.
About this company
PharmaCyte Biotech last closed at $0.3901 (-2.50%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C · 544/741
Valuation grade C+
Related stocks
- ModernaCompetitor
mRNA·세포/유전자치료 등 차세대 항암·치료제 개발 경쟁
- BioNTechCompetitor
면역항암·RNA 기반 치료제 개발 분야의 대표 경쟁사
- Gilead SciencesCompetitor
항암·세포치료/면역치료 영역에서 경쟁하는 대형 바이오 기업
About PharmaCyte Biotech
- What technical signals does PharmaCyte Biotech (PMCB) have?
- PharmaCyte Biotech current technical signals: no active technical signal.
- Is PharmaCyte Biotech a cup-and-handle pattern?
- No. PharmaCyte Biotech has no valid Cup signal right now.
- What published figures are available for PharmaCyte Biotech?
- Market cap: $3.95M. Trailing 12 months PER: -0.3×. Latest quarter PBR: 0.14×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about PharmaCyte Biotech, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy